68166 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Abbott Laboratories revenue reports

Abbott Laboratories financial reports, Abbott Laboratories annual revenue in 2019. When does Abbott Laboratories report revenue?
Add to widgets
Added to widgets
Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2019 7 535 000 000 $ +1.96 % ↑ 672 000 000 $ +60.77 % ↑
31/12/2018 7 765 000 000 $ +2.32 % ↑ 654 000 000 $ -
30/09/2018 7 656 000 000 $ +12.11 % ↑ 563 000 000 $ -6.633 % ↓
30/06/2018 7 767 000 000 $ +17.03 % ↑ 733 000 000 $ +159.01 % ↑
31/03/2018 7 390 000 000 $ - 418 000 000 $ -
31/12/2017 7 589 000 000 $ - -828 000 000 $ -
30/09/2017 6 829 000 000 $ - 603 000 000 $ -
30/06/2017 6 637 000 000 $ - 283 000 000 $ -
Show:
to

Abbott Laboratories financial report charts

Abbott Laboratories quarterly report dates

31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
4 375 000 000 $ 4 574 000 000 $ 4 490 000 000 $ 4 485 000 000 $ 4 323 000 000 $ 4 326 000 000 $ 3 972 000 000 $ 3 464 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
3 160 000 000 $ 3 191 000 000 $ 3 166 000 000 $ 3 282 000 000 $ 3 067 000 000 $ 3 263 000 000 $ 2 857 000 000 $ 3 173 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
7 535 000 000 $ 7 765 000 000 $ 7 656 000 000 $ 7 767 000 000 $ 7 390 000 000 $ 7 589 000 000 $ 6 829 000 000 $ 6 637 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
7 535 000 000 $ 7 765 000 000 $ 7 656 000 000 $ 7 767 000 000 $ 7 390 000 000 $ 7 589 000 000 $ 6 829 000 000 $ 6 637 000 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
739 000 000 $ 1 165 000 000 $ 995 000 000 $ 882 000 000 $ 608 000 000 $ 691 000 000 $ 810 000 000 $ 427 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
672 000 000 $ 654 000 000 $ 563 000 000 $ 733 000 000 $ 418 000 000 $ -828 000 000 $ 603 000 000 $ 283 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
672 000 000 $ 562 000 000 $ 574 000 000 $ 575 000 000 $ 589 000 000 $ 613 000 000 $ 562 000 000 $ 513 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
3 636 000 000 $ 3 409 000 000 $ 3 495 000 000 $ 3 603 000 000 $ 3 715 000 000 $ 3 635 000 000 $ 3 162 000 000 $ 3 037 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
- - - - 14 964 000 000 $ 20 147 000 000 $ 21 377 000 000 $ 19 983 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
- - - - 70 908 000 000 $ 76 250 000 000 $ 72 248 000 000 $ 71 151 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
- - - - 3 857 000 000 $ 9 407 000 000 $ 11 012 000 000 $ 9 675 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 737 000 000 $ 714 000 000 $ 715 000 000 $ 221 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - 4 042 000 000 $ 9 610 000 000 $ 11 199 000 000 $ 9 835 000 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 21 891 000 000 $ 27 924 000 000 $ 24 025 000 000 $ 24 031 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 30.87 % 36.62 % 33.25 % 33.77 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
- - - - 31 399 000 000 $ 30 897 000 000 $ 32 032 000 000 $ 31 602 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 1 108 000 000 $ 1 640 000 000 $ 2 005 000 000 $ 1 351 000 000 $

Last revenue report of Abbott Laboratories was 31/03/2019. According to last financial report total revenue in Abbott Laboratories was 7 535 000 000 US dollar and changed by +1.96% since last year. Net income in Abbott Laboratories was 672 000 000 $ in last quartal, net income changes to +60.77%.

Abbott Laboratories stocks data

Abbott Laboratories financials